Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

US HealthVest

Request full access

Behavioral healthcare firm that helps the development of psychiatric hospitals

New York City, United StatesFounded 2012Biotech & Life Sciences

About US HealthVest

USHealthVest is a healthcare startup that specializes in providing high-quality, personalized behavioral health services. Their primary focus is on psychiatric and substance abuse care, serving a wide range of clients including children, adolescents, adults, and seniors. The company operates in the behavioral healthcare market, with a portfolio of psychiatric hospitals located in Chicago, Atlanta, Seattle, and Indianapolis.

USHealthVest's business model is centered around the development and operation of newly constructed and renovated hospitals. These facilities offer a full continuum of care, ranging from inpatient and residential services to day hospital services. This comprehensive approach allows the company to cater to the unique needs of each patient, ensuring they receive the most appropriate and effective care.

One of the standout features of USHealthVest's service offering is their commitment to accessibility. They offer mental health and addiction crisis assessments 24 hours a day, seven days a week, at no charge. This service is available to everyone, regardless of their ability to pay, demonstrating the company's dedication to serving their local communities.

USHealthVest generates revenue through the provision of their various healthcare services. This includes income from patient fees for inpatient, residential, and day hospital services. The company's growth strategy involves developing new hospitals and services to increase access to behavioral healthcare in each community they serve.

Source: Dealroom company data

At a glance

Status
Operational
Employees
48
Open positions
1
Dealroom signal
81.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Hospital, Biotech and Pharma, Addiction, Hard Tech, elderly care, DT and LS, science-based
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Apr 2019 $55M — Standard Treasury —
LATE VCOther financing Nov 2018 $20M $80M Eight Roads Ventures · F-Prime —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

US HealthVest website traffic

Latest recorded traffic for US HealthVest is 1.8K monthly website visits, up 38.5% over the last three months. US HealthVest's team grew 9.1% over the past year.

Latest monthly visits1.8K 3-month web change+38.5% 1-year team growth+9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Emerzene IncRevolutionize CRISPR gene editing for non-addictive pain relief Dublin, Ireland Operational — $5.3M —
Empyrean NeuroscienceUsing genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare New York City, United States Operational
Diamond TherapeuticsDeveloping accessible, low-dose therapies for mental health conditions Toronto, Canada Operational
DemeRxDemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates as medication-assisted therapies for opioid addiction Fort Lauderdale, United States Operational
SideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers Paris, France Closed
CybinCybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms Ontario, United States Operational
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational
Kinoxis TherapeuticsA biotechnology startup developing new therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders Melbourne, Australia Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

US HealthVest in the New York City ecosystem

Live from Dealroom

The US HealthVest office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later2 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about US HealthVest on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See US HealthVest’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.